53 related articles for article (PubMed ID: 9989812)
41. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
Wu Z; Wang G; Zhang K
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):128-32. PubMed ID: 24463134
[TBL] [Abstract][Full Text] [Related]
42. Regulation of apoptosis in prostate cancer.
Gurumurthy S; Vasudevan KM; Rangnekar VM
Cancer Metastasis Rev; 2001; 20(3-4):225-43. PubMed ID: 12085964
[TBL] [Abstract][Full Text] [Related]
43. A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.
Rasool RU; Nayak D; Chakraborty S; Katoch A; Faheem MM; Amin H; Goswami A
Clin Exp Metastasis; 2016 Dec; 33(8):757-764. PubMed ID: 27568374
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of apoptosis by the tumor suppressor Par-4.
Hebbar N; Wang C; Rangnekar VM
J Cell Physiol; 2012 Dec; 227(12):3715-21. PubMed ID: 22552839
[TBL] [Abstract][Full Text] [Related]
45. Prostate cancer: TRIM24 acts as a transcriptional activator.
Stone L
Nat Rev Urol; 2016 Aug; 13(8):437. PubMed ID: 27296649
[No Abstract] [Full Text] [Related]
46. Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
Cheratta AR; Thayyullathil F; Pallichankandy S; Subburayan K; Alakkal A; Galadari S
Cell Death Dis; 2021 Jan; 12(1):47. PubMed ID: 33414404
[TBL] [Abstract][Full Text] [Related]
47. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
Qiu G; Ahmed M; Sells SF; Mohiuddin M; Weinstein MH; Rangnekar VM
Oncogene; 1999 Jan; 18(3):623-31. PubMed ID: 9989812
[TBL] [Abstract][Full Text] [Related]
48. Par-4 inducible apoptosis in prostate cancer cells.
Gurumurthy S; Rangnekar VM
J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
[TBL] [Abstract][Full Text] [Related]
49. Par-4 for molecular therapy of prostate cancer.
Butler J; Rangnekar VM
Curr Drug Targets; 2003 Apr; 4(3):223-30. PubMed ID: 12643472
[TBL] [Abstract][Full Text] [Related]
50. Molecular therapy intervention prospects in prostate cancer.
Rege YD; Rangnekar VM
Curr Pharm Des; 2004; 10(5):523-30. PubMed ID: 14965337
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis by Par-4 in cancer and neurodegenerative diseases.
El-Guendy N; Rangnekar VM
Exp Cell Res; 2003 Feb; 283(1):51-66. PubMed ID: 12565819
[TBL] [Abstract][Full Text] [Related]
52. Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders.
Mattson MP; Duan W; Chan SL; Camandola S
J Mol Neurosci; 1999; 13(1-2):17-30. PubMed ID: 10691289
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
